Leadtek Research (TPE:2465) ROCE %: 20.76% (As of Dec. 2025)


TPE:2465 Leadtek Research Inc TPE:2465
66 GF Score
Price NT$81.40
GF Value NT$55.83
Valuation Significantly Overvalued
! 3 Warning Signs
View Full Analysis

What is Leadtek Research ROCE %?

Leadtek Research TPE:2465 +10.00% 66 ROCE % is 20.76% as of Dec. 2025. GuruFocus rates TPE:2465 with a GF Score™ of 66/100 and a GF Value™ of NT$55.83 (Significantly Overvalued). The stock has 3 warning signs investors should review.

ROCE % measures how well a company generates profits from its capital. It is calculated as EBIT divided by Capital Employed, where Capital Employed is calculated as Total Assets minus Total Current Liabilities. Leadtek Research's annualized ROCE % for the quarter that ended in Dec. 2025 was 20.76%.


Leadtek Research  (TPE:2465) ROCE % Explanation

ROCE % can be especially useful when comparing the performance of capital-intensive companies. Unlike ROE %, which indicates the profitability of Shareholders Equity, ROCE % also considers long-term debt in Capital Employed. This can be helpful when analyzing companies with significant debt, as the result is neutralized by taking debt into consideration.

Generally speaking, a higher ROCE % indicates a stonger profitability for a company. Moreover, it is important to look at the ratio from a long term perspective. Investors tend to favor companies with stable and rising ROCE % trend over those with volatile ones.


Leadtek Research ROCE % Related Terms


Leadtek Research ROCE % Historical Data

* Premium members only.

The historical data trend for Leadtek Research's ROCE % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Leadtek Research ROCE % Chart

Leadtek Research Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
ROCE %
Get a 7-Day Free Trial Premium Member Only Premium Member Only 87.32 -23.15 -10.84 -26.66 9.77

Leadtek Research Quarterly Data
Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25
ROCE % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 6.74 13.53 6.78 -2.96 20.76
TPE:2465
66GF Score
Leadtek Research Inc TPE:2465
ROCE % is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Leadtek Research ROCE % Calculation

Leadtek Research's annualized ROCE % for the fiscal year that ended in Dec. 2025 is calculated as:

ROCE %=EBIT/( (Capital Employed+Capital Employed)/ count )
(A: Dec. 2025 )  (A: Dec. 2024 )(A: Dec. 2025 )
=EBIT/( ( (Total Assets - Total Current Liabilities)+(Total Assets - Total Current Liabilities) )/ count )
(A: Dec. 2025 )  (A: Dec. 2024 )(A: Dec. 2025 )
=91.931/( ( (2968.614 - 2228.983) + (1499.262 - 356.865) )/ 2 )
=91.931/( (739.631+1142.397)/ 2 )
=91.931/941.014
=9.77 %

Leadtek Research's ROCE % of for the quarter that ended in Dec. 2025 is calculated as:

ROCE %=EBIT (1)/( (Capital Employed+Capital Employed)/ count )
(Q: Dec. 2025 )  (Q: Sep. 2025 )(Q: Dec. 2025 )
=EBIT/( ( (Total Assets - Total Current Liabilities)+(Total Assets - Total Current Liabilities) )/ count )
(Q: Dec. 2025 )  (Q: Sep. 2025 )(Q: Dec. 2025 )
=185.184/( ( (1525.512 - 883.818) + (1499.262 - 356.865) )/ 2 )
=185.184/( ( 641.694 + 1142.397 )/ 2 )
=185.184/892.0455
=20.76 %

(1) Note: The EBIT data used here is four times the quarterly (Dec. 2025) EBIT data.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about ROCE % →
What does a ROCE % of 20.76% mean?
Leadtek Research (TPE:2465) has a ROCE % of 20.76% as of Dec. 2025.
Is Leadtek Research's ROCE % too high?
Leadtek Research's current ROCE % is 20.76%. The Hardware industry median ROCE % is 5.86. Leadtek Research's value of 20.76% is 254.6% above this industry median. Overall, Leadtek Research has a GF Score™ of 66/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Leadtek Research's ROCE % compare to SNDK and DELL?
Leadtek Research's ROCE % of 20.76% can be compared against companies in the Hardware industry. The industry median ROCE % is 5.86. Leadtek Research's value of 20.76% is 254.6% above this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good ROCE % for a Hardware company?
The median ROCE % among Hardware companies is 5.86, based on 2,446 companies in the industry. Companies in the top quartile (top 25%) have a ROCE % significantly above this median, while those in the bottom quartile fall well below. However, ROCE % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Leadtek Research's current ROCE % of 20.76% is 254.6% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high ROCE % mean?
A high ROCE % can signal that a stock is expensive relative to its fundamentals. For the Hardware industry, the median ROCE % is 5.86 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Leadtek Research's current ROCE % is 20.76%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Leadtek Research stock overvalued right now?
Based on GuruFocus' analysis, Leadtek Research (TPE:2465) is currently considered Significantly Overvalued. The stock's GF Value™ is NT$55.83, compared to a current price of NT$81.40 — trading 45.8% above its estimated fair value. The current ROCE % is 20.76% and 254.6% above the Hardware industry median of 5.86. Leadtek Research's overall GF Score™ is 66/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is ROCE % calculated?
ROCE % is calculated from a company's financial statements. For Leadtek Research (TPE:2465), the current ROCE % is 20.76% as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Leadtek Research (TPE:2465) Overvalued in 2026?

Based on GuruFocus' analysis, Leadtek Research stock appears to be overvalued. The current stock price of NT$81.40 is trading 45.8% above its estimated GF Value™ of NT$55.83. GuruFocus considers Leadtek Research to be Significantly Overvalued.

Key valuation signals for TPE:2465:

  • ROCE %: 20.76%
  • GF Value™: NT$55.83 vs. price of NT$81.40 (45.8% above fair value)
  • GF Score™: 66/100 with 3 warning signs
  • Industry Position: 254.6% above the Hardware median

No single metric tells the full story. See the TPE:2465 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Leadtek Research Business Description

Address No. 166, Jian 1st Road, 18th Floor, Zhonghe District, New Taipei City, TWN
Leadtek Research Inc is the design, manufacturing, and trading of communication devices, computers, communications, telecommunications, and peripheral equipment. Company has two reportable segments: the computer product department and the smart healthcare department. The products offered by the company include computer entertainment graphics cards, AI Inference devices, AI cloud supercomputing workstations, GPU-based AI workstations, servers, and professional graphics cards (WinFast/RTX). The company has expanded beyond computer hardware into smart medical healthcare, offering AI-driven diagnostic devices, wearable ECG monitors, and health management platforms and others. Geographically, company's regional market includes Mainland China, Taiwan, USA, Hong Kong, Korea and other countries.
66GF Score

Get the complete analysis for TPE:2465

ROCE % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

NT$81.40
Price
NT$55.83
GF Value